Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DAB-720: a new EGF receptor TK inhibitor from Mitsubishi Chemical

Oct. 28, 1997

Mechanism of action and in vivo antitumor efficacy reported for CS-682

Oct. 28, 1997

Novel antiangiogenic agent with oral activity in animal model of breast cancer

Oct. 28, 1997

SuperGen files supplemental NDA for Nipent

Oct. 27, 1997

Apoptotic effects described for antiestrogen

Oct. 27, 1997

Possible MDR-modulating effect described for E-6123, a PAF antagonist

Oct. 27, 1997

Antiangiogenic agent TNP-470 suppresses tumorigenesis in animal model

Oct. 27, 1997

Mechanism of action elucidated for anthracycline developed by Sumitomo

Oct. 27, 1997

TOP-53: preclinical antitumor activity and pharmacokinetics

Oct. 27, 1997

Photofrin now available in France and Germany

Oct. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...